IL6 and systemic sclerosis: We chose to inhibit IL-6, TNF-α/-β and galectin-3 in various combinations, in 2D cocultures between healthy activated B-cells and healthy or SSc fibroblasts separated by transwells to forbid direct contact between cell types (Figure 6A).